HARVEY SEROTA: Open Payments
NPI 1346264017 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$113,220 in 119 payments from 22 companies in 2025. Trend: 2023 $179,158 · 2024 $135,188 · 2025 $113,220
Speaker / faculty: $93,070Travel & lodging: $16,954Food & beverage: $3,183Education: $12
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 53 | $111,566 |
| CVRx, Inc. | 2 | $256 |
| Amgen Inc. | 12 | $200 |
| E.R. Squibb & Sons, L.L.C. | 3 | $176 |
| Novartis Pharmaceuticals Corporation | 19 | $158 |
| Vifor Pharma, Inc. | 2 | $144 |
| Impulse Dynamics (USA) Inc. | 1 | $132 |
| Novo Nordisk Inc | 6 | $99 |
| Cardiac Dimensions, Inc. | 1 | $90 |
| AstraZeneca Pharmaceuticals LP | 4 | $75 |
Products named: Kerendia, Barostim Neo System, REPATHA, LEQVIO, CAMZYOS, Optimizer, Veltassa, NEXLETOL.
Industry payments across MO — which companies pay providers there.
